14 August 2018
Visiongain has launched a new pharma report The Molecular Diagnostics (MDx) Market Forecast 2017-2027: Infectious Disease Testing, Oncology Testing, Blood Screening, Genetic Testing, Tissue Typing
Molecular diagnostics is a fast-growing and rapidly evolving sector of the IVD market, made possible by the growing understanding of the human genome. Molecular diagnostics tests have also led to the emerging field of companion diagnostics, in which a MDx test is used to identify whether a specific therapy is likely to be effective for an individual patient. The market for MDx is growing rapidly due to increasing biomarker discover and adoption rates, but its growth is limited by several regulatory and reimbursement issues.
The lead analyst of the report commented “There will be increasing adoption of molecular diagnostics over the forecast period as the benefits of increasing accuracy and speed of diagnosis become increasingly apparent. Another driver for the MDx industry will be the advent of Point-Of-Care MDx testing, which will greatly increase the potential availability of molecular testing as it moves out of high and moderate complexity laboratories into primary care settings such as hospitals and physicians’ offices.
The advent of personalised healthcare is also being driven by molecular diagnostics, as the ability to better stratify patients with added genetic information will allow physicians to select treatments that have a higher chance of success in an individual patient, as well as allowing for more detailed monitoring and evaluation of disease progression”
Leading companies featured in the report include Roche Diagnostics, Qiagen, Hologic, bioMérieux, Agilent Technologies, Becton, Dickinson & Company,
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
. The growth of this market is majorly driven by increasing sales of temperature sensitive pharmaceutical products, longer life expectancy and rising geriatric population are some of the prominent factors.
16 September 2020
Visiongain forecasts a continuing growth in global market, submarket and product sales as human vaccines drive pharmaceutical business sales. New key players and technological progress will enter the industry, leading to an increase in the market size of the world market for human vaccines in general.
14 September 2020
The global ophthalmic ultrasound systems market is driven by factors such as the increasing prevalence of ocular disorders and diseases, adoption of novel ophthalmic technologies, rising focus on research & development, and growing health awareness amongst the population.
09 September 2020
The current COVID-19 pandemic is anticipated to have a minor impact on the overall outsourcing business outlook for global drug discovery. Also, significant growth during the COVID-19 pandemic is expected to be seen in the outsourcing of drugs and medicines needed to treat COVID-19 infections.